Dr. Mohamed Elkasaby, a University Hospitals neurologist specializing in movement disorders and behavioral neurology, is available to see patients in Ashland, Ohio—home of UH Samaritan Medical Center—alongside his Cleveland and Beachwood locations.
That means people in the Ashland area facing Parkinson's disease or dementia now have local access to a specialist whose clinical focus matches those exact conditions, according to his University Hospitals physician profile. One caveat worth stating plainly: UH's public materials confirm his Ashland availability and his dementia and Parkinson's focus, but no primary press release documents a formally named "Dementia Parkinson's Treatment Team" or a specific hire date. This article separates what is verified from what the title implies.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who is Dr. Elkasaby, and what does he treat?
- Where can you actually see him?
- What's actually confirmed versus implied by the title?
- Dementia treatments a specialist can discuss now
- Parkinson's options and what's still in the pipeline
- Frequently Asked Questions
Who is Dr. Elkasaby, and what does he treat?
Dr. Elkasaby is a neurologist whose listed clinical interests line up closely with the two conditions in the title. His UH profile names Parkinson's disease, dementia, tremor, and dystonia (sustained, involuntary muscle contractions) among his focus areas. He also performs two procedures that matter for advanced movement disorders.
One is botulinum toxin injections, used to calm overactive muscles in conditions like dystonia and tremor. The other is deep brain stimulation—a surgical therapy that places thin electrodes in the brain to reduce Parkinson's symptoms when medication alone falls short. His training spans three countries. He earned his MD from Ain Shams University in Egypt, completed neurology residency and board certification in Germany, and finished fellowships in movement disorders, neuromodulation, and behavioral neurology at University Hospitals.
Where can you actually see him?
Dr. Elkasaby is accepting new patients and lists three Ohio locations: Cleveland, Beachwood, and Ashland. Ashland is the site tied to the title, since it is home to UH Samaritan Medical Center. If you are near Ashland, know how neurology care is delivered there.
According to University Hospitals, UH Samaritan offers tele-neurology plus a weekly in-person neurology clinic. That mix matters: some visits may happen by video, and in-person specialist slots are limited to certain days. before you assume a given appointment will be face-to-face with Dr. Elkasaby in Ashland, confirm the format and location when you schedule. His specialist availability there is real, but weekly clinics fill quickly.
What's actually confirmed versus implied by the title?
The title reads as a personnel announcement, so it helps to know which parts are documented. None of this contradicts the title—it simply means the team label and the joining event are marketing framing rather than verified facts. For care decisions, the practical takeaway is straightforward: a matching specialist is available locally.
- Confirmed: Dr. Elkasaby is a UH neurologist with a dementia and Parkinson's focus who sees patients in Ashland.
- Confirmed: UH Samaritan provides neurology services through tele-neurology and a weekly in-person clinic.
- Not independently documented: a discrete, formally named "Dementia Parkinson's Treatment Team" at UH Samaritan.
- Not independently documented: an exact hire or announcement date, or that he "joined" the site as a brand-new appointment.
Dementia treatments a specialist can discuss now
If a family is weighing a dementia evaluation, recent drug approvals are worth understanding. Two therapies target early Alzheimer's by clearing amyloid, a protein that builds up in the brain. The FDA fully approved lecanemab (Leqembi) for early Alzheimer's in July 2023, with a once-every-four-weeks maintenance dose approved in January 2025 and a weekly at-home injection in August 2025, per the Alzheimer's Association.
A second drug, donanemab (Kisunla), was approved on July 2, 2024 for early symptomatic Alzheimer's and showed roughly 35% slower progression over 18 months versus placebo, according to the University of Wisconsin ADRC. Both drugs target early disease, not advanced dementia, and both carry monitoring requirements. A movement-disorders and behavioral-neurology specialist is the right person to explain whether a specific patient qualifies.
Parkinson's options and what's still in the pipeline
Parkinson's care is also changing, which affects what a specialist can offer. For advanced disease, the FDA approved Onapgo—a continuous under-the-skin apomorphine infusion—on February 4, 2025 to reduce "off" episodes, the periods when medication wears off, according to the Michael J. Fox Foundation. One drug is not yet available.
AbbVie submitted an FDA application for tavapadon on September 26, 2025; that is a filing, not an approval, and such reviews typically run about ten months. Do not expect to start it at an appointment today. These approvals sit alongside the procedural options Dr. Elkasaby performs, such as deep brain stimulation, giving patients more than one path when standard pills stop controlling symptoms.
Frequently Asked Questions
Is Dr. Elkasaby accepting new patients?
Yes. His University Hospitals profile lists him as accepting new patients in Cleveland, Beachwood, and Ashland, Ohio.
Will my Ashland visit be in person or by video?
It could be either. UH Samaritan offers tele-neurology and a weekly in-person clinic, so confirm the format when you schedule.
Does he treat conditions beyond Parkinson's and dementia?
Yes. His listed interests also include tremor and dystonia, and he performs botulinum toxin injections and deep brain stimulation.
